Cite
HARVARD Citation
, . et al. (2021). Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 397 (10279), pp. 1063-1074. [Online].